Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,075,023
+$339,888 QoQ
Shares Held
8,246
+3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#1,933
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Souders Financial Advisors holds $13,208,144 across 10 Drug Manufacturers - General names. ABBV ranks #2 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,235 | $5,079,586 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
8,246 | $2,075,023 | |
| 3 | AMGN |
Amgen Inc
|
5,104 | $1,848,260 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,395 | $1,592,757 | |
| 5 | JNJ |
Johnson & Johnson
|
3,322 | $843,688 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,223 | $407,193 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,899 | $397,520 | |
| 8 | AZN |
Astrazeneca PLC
|
1,928 | $365,587 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,075,023 | 8,246 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,735,135 | 7,978 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,758,002 | 7,694 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,796,981 | 7,761 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,518,557 | 8,181 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,449,288 | 11,690 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,034,227 | 17,075 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,411,703 | 22,340 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $3,760,404 | 21,924 | Shares | Sole | 2024-08-28 | |
| 2024-03-31 | $3,824,646 | 21,003 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $477,152 | 3,079 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $459,253 | 3,081 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $406,749 | 3,019 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $484,962 | 3,043 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $508,586 | 3,147 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $416,990 | 3,107 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $467,444 | 3,052 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $431,212 | 2,660 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $356,102 | 2,630 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $286,826 | 2,659 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $279,797 | 2,484 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $268,602 | 2,482 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $264,553 | 2,469 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $216,259 | 2,469 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $232,195 | 2,365 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||